BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tai H, Li C, Hung C, Yin L. Production of functional peptides with inhibition ability against angiotensin I-Converting enzyme using P. pastoris expression system. Journal of Food and Drug Analysis 2018;26:1097-104. [DOI: 10.1016/j.jfda.2018.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Xue L, Yin R, Howell K, Zhang P. Activity and bioavailability of food protein-derived angiotensin-I-converting enzyme-inhibitory peptides. Compr Rev Food Sci Food Saf 2021;20:1150-87. [PMID: 33527706 DOI: 10.1111/1541-4337.12711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gomes C, Ferreira D, Carvalho JPF, Barreto CAV, Fernandes J, Gouveia M, Ribeiro F, Duque AS, Vieira SI. Current genetic engineering strategies for the production of antihypertensive ACEI peptides. Biotechnol Bioeng 2020;117:2610-28. [PMID: 32369185 DOI: 10.1002/bit.27373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhan N, Wang T, Zhang L, Shan A. A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4. Braz J Microbiol 2020;51:999-1008. [PMID: 32415637 DOI: 10.1007/s42770-020-00291-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]